We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
+$355M
Cap. Flow
+$316M
Cap. Flow %
26.21%
Top 10 Hldgs %
40.06%
Holding
747
New
182
Increased
169
Reduced
181
Closed
163

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64M
2
MMP
Magellan Midstream Partners, L.P.
MMP
+$42.3M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$41.5M
4
PTCT icon
PTC Therapeutics
PTCT
+$39.1M
5
TARS icon
Tarsus Pharmaceuticals
TARS
+$31.8M

Top Sells

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$99.5M
2
KVSC
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
+$24.5M
3
TIOA
Tio Tech A Class A Ordinary Share
TIOA
+$22.2M
4
IMVT icon
Immunovant
IMVT
+$19.4M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$13.9M

Sector Composition

Rank Sector Weight
1 Healthcare 36.03%
2 Financials 28.77%
3 Technology 9.99%
4 Energy 5.75%
5 Consumer Discretionary 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHAP.WS
526
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$2.29K ﹤0.01%
72,080
+9,080
+14% +$387
MOBVW
527
DELISTED
Mobiv Acquisition Corp Warrant
MOBVW
$2.29K ﹤0.01%
100,096
+96
+0.1% +$4
FHLTW
528
DELISTED
Future Health ESG Corp. Warrant
FHLTW
$2.29K ﹤0.01%
114,360
– –
VHAQ.WS
529
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
$2.29K ﹤0.01%
113,700
-99,900
-47% -$2.67K
BOCNW
530
DELISTED
Blue Ocean Acquisition Corp Warrants
BOCNW
$2.16K ﹤0.01%
50,100
-26,102
-34% -$2.22K
IVCAW
531
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
$2.16K ﹤0.01%
50,200
-8,167
-14% -$354
PDYNW icon
532
Palladyne AI Corp Warrants
PDYNW
$169K
$2.08K ﹤0.01%
59,300
-200
-0.3% -$14
MEOAW
533
DELISTED
Minority Equality Opportunities Acquisition Inc. Warrants
MEOAW
$2K ﹤0.01%
25,000
-99,000
-80% -$5.6K
HUBCW icon
534
Hub Cyber Security Warrant 2/27/28
HUBCW
$181K
$1.99K ﹤0.01%
49,800
-200
-0.4% -$14
APMIW
535
DELISTED
AxonPrime Infrastructure Acquisition Corporation Warrants
APMIW
$1.96K ﹤0.01%
75,300
-700
-0.9% -$51
WTMAR
536
DELISTED
Welsbach Technology Metals Acquisition Corp. one right to receive 1/10th of a share of common stock
WTMAR
$1.93K ﹤0.01%
28,578
-500
-2% -$65
UPH.WS
537
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
$1.93K ﹤0.01%
96,797
+100
+0.1% +$2
MBAC.WS
538
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$1.9K ﹤0.01%
67,396
+42,396
+170% +$2.39K
PROCW
539
DELISTED
Procaps Group, S.A. Warrants
PROCW
$1.88K ﹤0.01%
10,000
– –
GSDWW
540
DELISTED
Global Systems Dynamics, Inc. Warrant
GSDWW
$1.86K ﹤0.01%
46,482
– –
IRAAW
541
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$1.84K ﹤0.01%
50,900
+900
+2% +$60
AOGOW
542
DELISTED
Arogo Capital Acquisition Corp. Warrant
AOGOW
$1.84K ﹤0.01%
40,000
– –
SWSSW
543
DELISTED
Clean Energy Special Situations Corp. Warrant
SWSSW
$1.79K ﹤0.01%
92,617
+200
+0.2% +$6
CSTA.WS
544
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$1.79K ﹤0.01%
29,000
– –
ACBAW
545
DELISTED
Ace Global Business Acquisition Ltd Warrant
ACBAW
$1.76K ﹤0.01%
35,000
– –
GGAAW
546
DELISTED
Genesis Growth Tech Acquisition Corp. Warrant
GGAAW
$1.75K ﹤0.01%
+13,497
New +$1.3K
REVBW icon
547
Revelation Biosciences Warrant
REVBW
$1.75K ﹤0.01%
98,296
– –
APGNW
548
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$1.72K ﹤0.01%
50,600
– –
APXIW
549
DELISTED
APx Acquisition Corp. I Warrant
APXIW
$1.65K ﹤0.01%
23,700
-5,407
-19% -$428
PFTAW
550
DELISTED
Perception Capital Corp. III Warrant
PFTAW
$1.59K ﹤0.01%
39,798
-202
-0.5% -$15
20 21
22
23 24

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q2 2023 Portfolio in Review

As of Q2 2023, Cowen and Company held 747 positions worth $1.21B, up 42% from $851M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cowen and Company deployed $316M of net new capital in Q2 2023, opening 182 new positions and adding to 169 existing holdings. Its largest new stake was NVIDIA: 1,927,500 shares worth $81.5M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Avadel Pharmaceuticals, an estimated $13.9M trimmed.

  • Cowen and Company's largest Q2 2023 buy was NVIDIA: 1,927,500 shares worth $81.5M.
  • Cowen and Company added most to Ares Acquisition Corporation in Q2 2023, an estimated $15.9M increase.
  • Cowen and Company's biggest Q2 2023 reduction was Avadel Pharmaceuticals, cutting an estimated $13.9M.
  • Cowen and Company fully exited Sylvamo in Q2 2023, selling an estimated $99.5M.
  • Cowen and Company's ten largest holdings make up 40% of its $1.21B portfolio in Q2 2023.
  • Cowen and Company opened 182 new positions and closed 163 in Q2 2023.
  • Cowen and Company's portfolio value rose 42% quarter-over-quarter to $1.21B.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.